These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 13261706)

  • 1. [The formation of neutralizing antibodies in humans after poliomyelitis immunization with the Behring vaccine].
    KELLER W; SAUTHOFF R
    Dtsch Med Wochenschr; 1955 Sep; 80(37):1329-31. PubMed ID: 13261706
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between specific skin reaction and neutralizing antibody titers in the young infant following immunization with poliomyelitis (Salk-type) vaccine.
    MORRONE G; NUNZIATA B
    Ann Paediatr; 1961; 196():389-98. PubMed ID: 13772899
    [No Abstract]   [Full Text] [Related]  

  • 3. [Variations in the neutralizing antibodies for 3 types of poliomyelitis virus following inoculation of inactivated vaccine].
    MAJORI L; GASPARINI V
    Riv Ist Sieroter Ital; 1959; 34():237-50. PubMed ID: 14420105
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination against poliomyelitis with live virus vaccines. 5. Neutralizing antibody levels one year after vaccination.
    DANE DS; DICK GW; BRIGGS M; NELSON R
    Br Med J; 1958 Nov; 2(5106):1187-8. PubMed ID: 13584893
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation.
    SALK JE; BAZELEY PL; BENNETT BL; KRECH U; LEWIS LJ; WARD EN; YOUNGNER JS
    Am J Public Health Nations Health; 1954 Aug; 44(8):994-1009. PubMed ID: 13180761
    [No Abstract]   [Full Text] [Related]  

  • 6. [On neutralizing antibodies before and after vaccination against poliomyelitis with Salk vaccine].
    GILLERT KE; GRUETZNER L; HARTMANN H
    Zentralbl Bakteriol; 1960 Feb; 177():289-98. PubMed ID: 13850076
    [No Abstract]   [Full Text] [Related]  

  • 7. [Examinations on poliomyelitis antibodies in the population and the practical significance of antibody determination in poliomyelitis vaccination].
    KELLER W
    Monatsschr Kinderheilkd (1902); 1956 Mar; 104(3):135-6. PubMed ID: 13321825
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observations on the possible variations of titer of natural anti-poliomyelitis neutralizing antibodies following heterologous immunity stimulation (antidiphtheria booster vaccination)].
    ROSA A; LA PLACA M
    Boll Ist Sieroter Milan; 1959; 38():315-7. PubMed ID: 14438769
    [No Abstract]   [Full Text] [Related]  

  • 9. NEUTRALIZING ANTIBODIES IN FAECAL EXTRACTS DURING POLIOMYELITIS LIVE VACCINE IMMUNIZATION.
    MASSON AM; ROGALA E; ROLLAND D
    Can J Public Health; 1965 Jul; 56():276-80. PubMed ID: 14343213
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of antibodies neutralizing the 3 types of poliovirus in children of the second and third stages of childhood given antipoliomyelitis vaccination with the Salk type of vaccine].
    SEGAGNI E; ANSALDI N; NIGRO N
    Minerva Pediatr; 1960 Apr; 12():518-22. PubMed ID: 14444520
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of poliomyelitis neutralizing antibodies in Norwegian school children before vaccination.
    ULSTRUP JC; MEMMER R
    Arch Gesamte Virusforsch; 1959; 9():348-59. PubMed ID: 13840330
    [No Abstract]   [Full Text] [Related]  

  • 12. Demonstration of neutralizing antibodies for poliomyelitis viruses.
    YOUNGNER JS
    Ann N Y Acad Sci; 1955 Sep; 61(4):774-80. PubMed ID: 13340583
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of poliomyelitis antibodies in Lorraine before, during and after vaccination with the Lepine vaccine in a group of subjects observed systematically].
    de LAVERGNE ; GERBAUT P; LORRAIN J; POLJE F; GILGENKRANTZ ; LE MOYNE MT; MATHIEU J
    Ann Inst Pasteur (Paris); 1959 Dec; 97():848-54. PubMed ID: 14414644
    [No Abstract]   [Full Text] [Related]  

  • 14. [Perioral administration of attenuated poliomyelitis vaccine (Cox type) into Japanese infants. Fecal excretion of the viruses and follow-up study of neutralizing antibody].
    ARAI M; KITAOKA M; TAKEMORI N; NOMURA S; NAKANO M; KARASAWA K; FURUMOTO H
    Paediatr Jpn; 1962 Apr; 66():227-34. PubMed ID: 13861967
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of neutralizing antibodies of poliomyelitis among the Africans (Negroes and pygmies) of the Belgian Congo].
    BARSKI G; LEPINE P
    Bull World Health Organ; 1956; 14(1):119-28. PubMed ID: 13329841
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the relation between skin reactivity to the specific antigen and titer of serum neutralizing antibodies in infants subjected to vaccination and in young children with poliomyelitis infection, respectively].
    MORMONE V; MORRONE G; NUNZIATA B
    Pharm Ind; 1960 Oct; 68():833-50. PubMed ID: 13772734
    [No Abstract]   [Full Text] [Related]  

  • 17. [Incidence of neutralizing antibodies against three types of poliomyelitis virus in several population groups in northern Italy].
    GIOVANARDI A; MONACI V; BONETTI F
    Boll Ist Sieroter Milan; 1955; 34(11-12):742-8. PubMed ID: 13293260
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-poliomyelitis vaccination with inactivated virus (Lepine vaccine). Effect of the booster injection on immunization].
    MARTIN R; ROGER F; DAMAS JP; ROGER A; JUILLARD P
    Bull Acad Natl Med; 1961 Nov 21-28; 145():664-73. PubMed ID: 14470436
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibody response of infants to a "booster" dose of the Salk type of poliomyelitis vaccine given from 5 to 6 months after early primary immunization].
    MORRONE G; NUNZIATA B
    Pediatria (Napoli); 1961; 69():851-6. PubMed ID: 14476315
    [No Abstract]   [Full Text] [Related]  

  • 20. [Poliomyelitis antibody development in adults after vaccination with Lederle triple vaccine of Sabin strains].
    GSELL O; WIESMANN E
    Schweiz Med Wochenschr; 1962 Apr; 92():475-6. PubMed ID: 13902511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.